Get started
Author

Shuanghui Chen

Observed names: S. Chen, Shuang-Jing Chen, Shuang-jing Chen
ORCID: 0009-0003-8206-0356
Observed ORCID: 0009-0003-8206-0356
OpenAlex ID: A5040972791
Intratumoral injection of R848 and poly(I:C) synergistically promoted antitumor immune responses by reprogramming macrophage polarization and activating DCs in lung cancer
2025 · Shuanghui Chen, Linzhao Li, et al. · Clinical & Experimental Immunology · 9
PDF
ADORA2B promotes proliferation and migration in head and neck squamous cell carcinoma and is associated with immune infiltration
2025 · Pian Li, Ke-ling Pang, et al. · BMC Cancer · 6
PDF
Anti-TNFR2 antibody and HMGN1 combined with TIL cell therapy inhibits colorectal cancer progression by enhancing immune response
2025 · Hang Lv, Yujie Nie, et al. · Biochemical and Biophysical Research Communications · 2
P3.03.23 Circular Rna Vaccine Synergizes With Anti-PD-1 to Augment Therapeutic Efficacy in Lung Cancer
2025 · S. Chen, Z. Liu, et al. · Journal of Thoracic Oncology · 1
Hypoxia-preconditioned mesenchymal stem cell-derived exosomes attenuate myocardial ischemia/reperfusion injury by miR-29b-3p via PINK1/Parkin-mediated mitophagy
2026 · Wen Wen, Chen-Xi Liu, et al. · World Journal of Stem Cells
PDF
P3.01-64 Preliminary Data of Diverse Therapies in Patients with Advanced Non–Small-Cell Lung Cancer Harbouring RET-Rearrangement
2018 · C. Lu, H. Tu, et al. · Journal of Thoracic Oncology
Works count: 6
Citation count: 18
H-index: 2
I10-index:
Year
Topic
Type